Abstract |
The IFCC Committee on Clinical Applications of Cardiac Bio-Markers (C-CB) has directives and initiatives focused on providing evidence-based educational resources to aid and improve understanding around key analytical and clinical aspects of cardiac biomarkers used in clinical practice and the research setting. As a task force, we have previously published position statements and recommendations focused on use and analytical aspects of high-sensitivity cardiac troponin assays. The current educational document is the first from the C-CB highlighting important biochemical, analytical, and clinical aspects as they relate to the natriuretic peptides (NPs), including B-type natriuretic peptide (BNP) and N-terminal pro- B-type natriuretic peptide ( NT-proBNP), with a focus on heart failure.
|
Authors | Peter A Kavsak, Carolyn S P Lam, Amy K Saenger, Allan S Jaffe, Paul Collinson, Kari Pulkki, Tobjørn Omland, Guillaume Lefèvre, Richard Body, Jordi Ordonez-Llanos, Fred S Apple |
Journal | Clinical chemistry
(Clin Chem)
Vol. 65
Issue 10
Pg. 1221-1227
(10 2019)
ISSN: 1530-8561 [Electronic] England |
PMID | 31387884
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Copyright | © 2019 American Association for Clinical Chemistry. |
Chemical References |
- Biomarkers
- Peptide Fragments
- pro-brain natriuretic peptide (1-76)
- Natriuretic Peptide, Brain
|
Topics |
- Biomarkers
(blood)
- Heart Failure
(blood)
- Humans
- Immunoassay
(methods)
- Natriuretic Peptide, Brain
(blood)
- Peptide Fragments
(blood)
|